May 14, 2026 10:47AM
Feb 27, 2026 12:29PM
Feb 12, 2026 08:00AM
Feb 12, 2026 08:00AM
Nov 7, 2025 08:00AM
Nov 3, 2025 08:00AM
Oct 28, 2025 08:00AM ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs
Oct 17, 2025 12:10PM
Oct 17, 2025 12:08PM
Aug 25, 2025 08:00AM
Jul 30, 2025 08:00AM
Jul 21, 2025 08:00AM
Jul 14, 2025 08:00AM
Jun 25, 2025 08:00AM ORYZON to Host Virtual KOL Event on July 9, 2025
Jun 23, 2025 08:00AM
Jun 17, 2025 08:00AM
May 27, 2025 08:00AM
May 12, 2025 08:00AM
May 8, 2025 08:00AM
Apr 24, 2025 08:00AM
Apr 21, 2025 08:00AM ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
Mar 14, 2025 08:00AM
Mar 5, 2025 08:00AM
Mar 3, 2025 08:00AM
Feb 27, 2025 04:03PM
Feb 14, 2025 08:00AM
Jan 10, 2025 08:00AM
Dec 2, 2024 08:00AM ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
Oct 24, 2024 12:08PM
Oct 1, 2024 07:00AM
Sep 23, 2024 08:00AM
Sep 11, 2024 12:07PM
Sep 9, 2024 08:00AM
Sep 3, 2024 08:00AM
Aug 29, 2024 08:14AM ORYZON to Provide Corporate Progress Updates at Several Events in September
Jul 31, 2024 08:32AM
Jul 8, 2024 08:00AM
Jun 26, 2024 08:00AM
Jun 14, 2024 08:00AM
Jun 3, 2024 08:00AM
May 30, 2024 08:00AM
May 9, 2024 08:00AM ORYZON to Provide Corporate Progress Updates at Several Events in May
May 6, 2024 12:03PM
Apr 22, 2024 08:00AM
Apr 8, 2024 08:00AM
Apr 5, 2024 08:00AM
Feb 26, 2024 02:28PM
Feb 5, 2024 08:00AM
Jan 19, 2024 08:00AM ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024
Jan 5, 2024 03:47PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All